Loading...
Docoh

scPharmaceuticals (SCPH)

229 filings

Newest first
Filter options loading...
Top filers
Top filing types
Recent filing years
8-K
SCPH scPharmaceuticals Inc
9 Aug 22
Announced FDA acceptance of FUROSCIX® New Drug Application and Prescription Drug User-Fee Act
7:14am
8-K
SCPH scPharmaceuticals Inc
12 Jul 22
Study results favor FUROSCIX® versus “treatment as usual” in composite primary endpoint and all secondary endpoints
8:08am
4
SCPH scPharmaceuticals Inc
15 Jun 22
scPharmaceuticals / Sara Bonstein ownership change
4:30pm
4
SCPH scPharmaceuticals Inc
15 Jun 22
scPharmaceuticals / Frederick M. Hudson ownership change
4:30pm
8-K
SCPH scPharmaceuticals Inc
15 Jun 22
Submission of Matters to a Vote of Security Holders
4:30pm
4
SCPH scPharmaceuticals Inc
15 Jun 22
scPharmaceuticals / KLAUS R DR VEITINGER ownership change
4:30pm
4
Baylor-Henry Minnie
15 Jun 22
scPharmaceuticals / Minnie Baylor-Henry ownership change
4:30pm
4
SCPH scPharmaceuticals Inc
15 Jun 22
scPharmaceuticals / Jack A. Khattar ownership change
4:30pm
4
SCPH scPharmaceuticals Inc
15 Jun 22
scPharmaceuticals / LEONARD D SCHAEFFER ownership change
4:30pm
4
William Tober Abraham
14 Jun 22
scPharmaceuticals / William Tober Abraham ownership change
8:00pm
10-Q
2022 Q1
SCPH scPharmaceuticals Inc
16 May 22
Quarterly report
4:02pm
8-K
SCPH scPharmaceuticals Inc
16 May 22
Continuing to ramp up commercial readiness activities in advance of an anticipated Q4 2022 launch of FUROSCIX®, if approved
7:26am
8-K
SCPH scPharmaceuticals Inc
16 May 22
Company preparing for Q4 commercial launch, if approved
7:14am
DEFA14A
SCPH scPharmaceuticals Inc
28 Apr 22
Additional proxy soliciting materials
4:02pm
DEF 14A
SCPH scPharmaceuticals Inc
28 Apr 22
Definitive proxy
4:00pm
4
5AM Opportunities I
13 Apr 22
scPharmaceuticals / SCOTT M ROCKLAGE ownership change
4:51pm
8-K
SCPH scPharmaceuticals Inc
11 Apr 22
Anticipates Q4 2022 commercial launch, if approved
7:44pm
S-8
SCPH scPharmaceuticals Inc
22 Mar 22
Registration of securities for employees
4:08pm
10-K
2021 FY
SCPH scPharmaceuticals Inc
22 Mar 22
Annual report
4:01pm
8-K
SCPH scPharmaceuticals Inc
22 Mar 22
Commercial preparedness activities ramping up to support anticipated Q4 2022 launch of FUROSCIX, if approved
7:11am